Free tool
FAERS Monitor: Zyprexa Zydis
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021086 or its brand name (Zyprexa Zydis, Olanzapine). Reports on generic versions are filed under their own applications.
Reports
108,793
Serious
93,787
86% of reports
Hospitalization
47,892
Death reported
13,437
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective7,554
- weight increased6,911
- off label use6,123
- diabetes mellitus5,418
- toxicity to various agents4,386
- drug interaction4,297
- nausea4,140
- somnolence4,027
- fatigue3,681
- overdose3,489
- anxiety3,483
- vomiting3,357
- suicide attempt3,256
- condition aggravated3,029
- confusional state2,932
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2,202 |
| 2005 | 3,180 |
| 2006 | 3,626 |
| 2007 | 3,557 |
| 2008 | 1,873 |
| 2009 | 3,627 |
| 2010 | 3,267 |
| 2011 | 3,309 |
| 2012 | 2,988 |
| 2013 | 2,576 |
| 2014 | 2,974 |
| 2015 | 8,028 |
| 2016 | 3,932 |
| 2017 | 4,830 |
| 2018 | 6,096 |
| 2019 | 6,696 |
| 2020 | 6,173 |
| 2021 | 6,278 |
| 2022 | 7,109 |
| 2023 | 6,892 |
| 2024 | 7,042 |
| 2025 | 7,220 |
| 2026 | 5,317 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,945,366 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| diabetes mellitusSignal | 5,418 | 14.7 | 14.3 | 64,555 |
| suicide attemptSignal | 3,256 | 10.9 | 10.5 | 27,818 |
| weight increasedSignal | 6,911 | 6.1 | 6.0 | 29,022 |
| drug interactionSignal | 4,297 | 5.4 | 5.2 | 14,913 |
| toxicity to various agentsSignal | 4,386 | 5.1 | 5.0 | 14,338 |
| somnolenceSignal | 4,027 | 3.9 | 3.8 | 8,683 |
| confusional stateSignal | 2,932 | 3.6 | 3.4 | 5,323 |
| overdoseSignal | 3,489 | 3.2 | 3.1 | 5,124 |
| anxietySignal | 3,483 | 2.4 | 2.3 | 2,798 |
| condition aggravated | 3,029 | 1.9 | 1.9 | 1,375 |
| vomiting | 3,357 | 1.4 | 1.3 | 361 |
| off label use | 6,123 | 1.4 | 1.3 | 588 |
| drug ineffective | 7,554 | 1.1 | 1.1 | 85 |
| nausea | 4,140 | 1.0 | 1.0 | 1 |
| fatigue | 3,681 | 0.9 | 0.9 | 31 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.